Biotage AB Total Liabilities

Latest as of March 2025: Skr862.00 Million SEK ≈ $92.76 Million USD

Biotage AB total liabilities. Based on the latest financial reports, Biotage AB (BIOT) has total liabilities worth Skr862.00 Million SEK (≈ $92.76 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BIOT cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Biotage AB (2000–2024)

Total liabilities of Biotage AB from 2000 to 2024. This chart illustrates how Biotage AB's total liabilities have evolved over time, based on quarterly financial data. Check BIOT financial resilience to evaluate the company's liquid asset resilience ratio.

Biotage AB Competitors by Total Liabilities

The table below lists competitors of Biotage AB ranked by their total liabilities.

Company Country Total Liabilities
Jungheinrich AG O.N.VZO
XETRA:JUN3
Germany €5.88 Billion
Shenzhen Noposion Agrochemicals Co Ltd
SHE:002215
China CN¥7.29 Billion
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
China CN¥2.80 Billion
Treehouse Foods Inc
NYSE:THS
USA $2.51 Billion
NMDC Steel Limited
NSE:NSLNISP
India Rs-131.73 Billion
Tourmaline Bio Inc.
NASDAQ:TRML
USA $10.10 Million
West China Cement Limited
F:WFG1
Germany €21.32 Billion
China National Electric Apparatus R
SHG:688128
China CN¥4.81 Billion

Liability Composition Analysis (2000–2024)

This chart breaks down Biotage AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Biotage AB total assets.

Liquidity & Leverage Metrics

Biotage AB Total Liabilities Ratios Explained

Biotage AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.53 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.88 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotage AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotage AB (2000–2024)

The table below shows the annual total liabilities of Biotage AB from 2000 to 2024.

Year Total Liabilities Change
2024-12-31 Skr991.00 Million
≈ $106.65 Million
-22.21%
2023-12-31 Skr1.27 Billion
≈ $137.10 Million
+81.48%
2022-12-31 Skr702.00 Million
≈ $75.55 Million
+13.23%
2021-12-31 Skr620.00 Million
≈ $66.72 Million
+39.51%
2020-12-31 Skr444.40 Million
≈ $47.82 Million
-3.43%
2019-12-31 Skr460.19 Million
≈ $49.52 Million
+52.87%
2018-12-31 Skr301.02 Million
≈ $32.39 Million
+102.59%
2017-12-31 Skr148.59 Million
≈ $15.99 Million
+12.60%
2016-12-31 Skr131.96 Million
≈ $14.20 Million
+8.01%
2015-12-31 Skr122.17 Million
≈ $13.15 Million
+5.00%
2014-12-31 Skr116.36 Million
≈ $12.52 Million
+0.77%
2013-12-31 Skr115.47 Million
≈ $12.43 Million
-6.30%
2012-12-31 Skr123.24 Million
≈ $13.26 Million
-8.81%
2011-12-31 Skr135.16 Million
≈ $14.55 Million
+7.71%
2010-12-31 Skr125.48 Million
≈ $13.50 Million
-9.31%
2009-12-31 Skr138.36 Million
≈ $14.89 Million
-20.58%
2008-12-31 Skr174.22 Million
≈ $18.75 Million
-9.42%
2007-12-31 Skr192.33 Million
≈ $20.70 Million
-6.08%
2006-12-31 Skr204.79 Million
≈ $22.04 Million
-13.40%
2005-12-31 Skr236.49 Million
≈ $25.45 Million
+37.47%
2004-12-31 Skr172.03 Million
≈ $18.51 Million
-20.78%
2003-12-31 Skr217.15 Million
≈ $23.37 Million
+250.96%
2002-12-31 Skr61.88 Million
≈ $6.66 Million
+0.07%
2001-12-31 Skr61.83 Million
≈ $6.65 Million
+20.98%
2000-12-31 Skr51.11 Million
≈ $5.50 Million
--

About Biotage AB

ST:BIOT Sweden Medical Instruments & Supplies
Market Cap
$1.23 Billion
Skr11.46 Billion SEK
Market Cap Rank
#7792 Global
#128 in Sweden
Share Price
Skr143.20
Change (1 day)
+0.00%
52-Week Range
Skr143.20 - Skr143.20
All Time High
Skr280.87
About

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation produ… Read more